Stock VIGL VIGIL NEUROSCIENCE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Vigil Neuroscience, Inc.

Equities

VIGL

US92673K1088

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
3.18 USD -0.62% Intraday chart for Vigil Neuroscience, Inc. -12.40% -5.92%
May. 07 Vigil Neuroscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 17 Vigil Neuroscience, Inc. Presents Key Findings from Illuminate & Ignite Studies in ALSP At the 2024 American Academy of Neurology Annual Meeting CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Vigil Neuroscience to Present in Upcoming June Investor Conferences
Vigil Neuroscience to Present at The Citizens JMP Life Sciences Conference
Vigil Neuroscience Reports First Quarter 2024 Financial Results and Provides Business Update
Vigil Neuroscience Reports First Quarter 2024 Financial Results and Provides Business Update
Vigil Neuroscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Vigil Presents Key Findings from ILLUMINATE & IGNITE Studies in ALSP at the 2024 American Academy of Neurology Annual Meeting
Vigil Neuroscience, Inc. Presents Key Findings from Illuminate & Ignite Studies in ALSP At the 2024 American Academy of Neurology Annual Meeting
Wedbush Trims Vigil Neuroscience Price Target to $22 From $23, Maintains Outperform Rating
Vigil Neuroscience Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Vigil Neuroscience, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Vigil Neuroscience, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
North American Morning Briefing : Markets Steady -2-
Vigil Neuroscience Names Petra Kaufmann Chief Medical Officer
Vigil Neuroscience Appoints Petra Kaufmann, M.D., as Chief Medical Officer
Vigil Neuroscience Appoints Petra Kaufmann, M.D., as Chief Medical Officer
Vigil Neuroscience, Inc. Announces Executive Changes
North American Morning Briefing : Stock Futures -2-
Vigil Announces Upcoming Presentations at 2024 American Academy of Neurology Annual Meeting
Vigil Announces Upcoming Presentations at 2024 American Academy of Neurology Annual Meeting
Vigil Neuroscience to Present at Stifel 2024 Virtual CNS Days
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. VIGL Stock
  4. News Vigil Neuroscience, Inc.
  5. Other languages